Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
Themis Bioscience GmbH
Emil C Reisinger; Roland Tschismarov; Eckhard Beubler; Ursula Wiedermann; Christa Firbas; Micha Loebermann; Andrea Pfeiffer; Matthias Muellner; Erich Tauber; Katrin Ramsauer